Toyama Chemical, NIDEK Receive Manufacturing Approval for New-quinolone Ophthalmic Solutions.Tokyo, Japan, Jan 24, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Toyama Chemical and NIDEK jointly announced on January 23 that they have received manufacturing approval for an ophthalmic solution ophthalmic solution n. A sterile solution that is free from foreign particles and is compounded and dispensed for eyedrops. made of tosufloxacin tosilate, a new quinolone agent, from the Ministry of Health, Labor and Welfare. The new agent, which was developed based on Toyama Chemical's antibacterial antibacterial /an·ti·bac·te·ri·al/ (-bak-ter´e-al) destroying or suppressing growth or reproduction of bacteria; also, an agent that does this. an·ti·bac·te·ri·al adj. agent Ozex Tablet See digitizer tablet and tablet computer. TABLET - A query language. ["Human Factor Comparison of a Procedural and a Non-procedural Query Language", C. Welty et al, ACM Trans Database Sys 6(4):626-649 (Dec 1981)]. , is indicated for the treatment of various eye infections such as blephartits, dacryocystitis, and hordeolum. The agent will be distributed through two sales channels: Ozex 0.3% by Toyama Chemical and Otsuka Pharmaceutical, and Tosflo 0.3% by NIDEK. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion